Raffa Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $212 | Sell |
1
-6
| -86% | -$1.18K | ﹤0.01% | 1257 |
|
|
2026
Q1 | $1.37K | Buy |
7
+2
| +40% | +$389 | ﹤0.01% | 862 |
|
|
2025
Q4 | $868 | Hold |
5
| – | – | ﹤0.01% | 956 |
|
|
2025
Q3 | $953 | Hold |
5
| – | – | ﹤0.01% | 905 |
|
|
2025
Q2 | $898 | Hold |
5
| – | – | ﹤0.01% | 895 |
|
|
2025
Q1 | $846 | Hold |
5
| – | – | ﹤0.01% | 869 |
|
|
2024
Q4 | $754 | Sell |
5
-13
| -72% | -$2.02K | ﹤0.01% | 928 |
|
|
2024
Q3 | $2.79K | Hold |
18
| – | – | ﹤0.01% | 546 |
|
|
2024
Q2 | $2.46K | Hold |
18
| – | – | ﹤0.01% | 670 |
|
|
2024
Q1 | $2.4K | Hold |
18
| – | – | ﹤0.01% | 661 |
|
|
2023
Q4 | $2.48K | Hold |
18
| – | – | ﹤0.01% | 552 |
|
|
2023
Q3 | $2.19K | Hold |
18
| – | – | ﹤0.01% | 557 |
|
|
2023
Q2 | $2.53K | Hold |
18
| – | – | ﹤0.01% | 541 |
|
|
2023
Q1 | $2.55K | Hold |
18
| – | – | ﹤0.01% | 547 |
|
|
2022
Q4 | $2.82K | Hold |
18
| – | – | ﹤0.01% | 498 |
|
|
2022
Q3 | $2.21K | Hold |
18
| – | – | ﹤0.01% | 564 |
|
|
2022
Q2 | $2.39K | Hold |
18
| – | – | ﹤0.01% | 563 |
|
|
2022
Q1 | $2.46K | Hold |
18
| – | – | ﹤0.01% | 587 |
|
|
2021
Q4 | $3.11K | Hold |
18
| – | – | ﹤0.01% | 541 |
|
|
2021
Q3 | $2.62K | Hold |
18
| – | – | ﹤0.01% | 541 |
|
|
2021
Q2 | $2.38K | Hold |
18
| – | – | ﹤0.01% | 576 |
|
|
2021
Q1 | $2.31K | Buy |
18
+5
| +38% | +$616 | ﹤0.01% | 593 |
|
|
2020
Q4 | $1.55K | Hold |
13
| – | – | ﹤0.01% | 619 |
|
|
2020
Q3 | $1.49K | Hold |
13
| – | – | ﹤0.01% | 564 |
|
|
2020
Q2 | $1.48K | Hold |
13
| – | – | ﹤0.01% | 542 |
|
|
2020
Q1 | $1.04K | Hold |
13
| – | – | ﹤0.01% | 581 |
|
|
2019
Q4 | $1.39K | Hold |
13
| – | – | ﹤0.01% | 500 |
|
|
2019
Q3 | $1.39K | Buy |
+13
| New | +$1.33K | ﹤0.01% | 481 |
|
|
2019
Q2 | – | Sell |
-13
| Closed | -$1.17K | – | 901 |
|
|
2019
Q1 | $1.17K | Hold |
13
| – | – | ﹤0.01% | 504 |
|
|
2018
Q4 | $1.08K | Hold |
13
| – | – | ﹤0.01% | 497 |
|
|
2018
Q3 | $1.4K | Hold |
13
| – | – | ﹤0.01% | 465 |
|
|
2018
Q2 | $1.43K | Hold |
13
| – | – | ﹤0.01% | 436 |
|
|
2018
Q1 | $1.3K | Buy |
+13
| New | +$1.33K | ﹤0.01% | 434 |
|
Other funds holding DGX
EIG
Raffa Wealth Management's DGX Position: Q2 2026 in Review
Raffa Wealth Management reduced its Quest Diagnostics (DGX) stake by 86% in Q2 2026, selling an estimated $1.18K and leaving 1 share worth $212. The position accounts for ﹤0.01% of the portfolio, ranked #1257.
Raffa Wealth Management first reported a position in DGX in Q1 2018 and has held it in 33 quarters since. The position peaked at $3.11K in Q4 2021. 1,046 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Raffa Wealth Management held 1 share of Quest Diagnostics worth $212 as of Q2 2026.
- Raffa Wealth Management sold 6 Quest Diagnostics shares in Q2 2026, an estimated $1.18K.
- Quest Diagnostics made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #1257 holding.
- Raffa Wealth Management first reported a position in Quest Diagnostics in Q1 2018 and has held it in 33 quarters since.
- Raffa Wealth Management's Quest Diagnostics position peaked at $3.11K in Q4 2021.
- 1,046 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.